Özge Atilgan Karakulak is a partner with the law firm of Gün + Partners which is internationally renowned for its expertise among others in intellectual property, and Turkish commercial and corporate law. Her practice focuses on patent rights, life sciences, antitrust and public procurement.
Özge has been involved in and has led many patent infringement actions against generic pharmaceutical companies and initiated with Mehmet Gün the first ever pharmaceutical data protection and exclusivity actions in Turkey. She combines her IP litigation expertise with her extensive knowledge of life science sectors. She advises a number of multinational life science companies on a wide range of matters including registration procedures, promotion practices, pricing and reimbursement regulations, distribution relationships and co-marketing deals, as well as on issues of merger control, vertical restraints and abusive conduct. She advised and represented a multinational pharmaceutical company in negotiating a contract with the Turkish Ministry of Health for the supply of H1N1 influenza vaccine.
She serves as a counsel to the Association of Research-Based Pharmaceutical Companies and the Association of Research-Based Medical Technologies Manufacturers in Turkey, and advises on many IP and regulatory policy papers and drafting laws and regulations proposed to the Turkish governmental authorities.
Özge holds an LLM in Business Law from Galatasaray University, Faculty of Law, Istanbul (2006) and an LLB from Dokuz Eylül University, Faculty of Law, Izmir (2004). She was educated at Wautoma High School, WI, US (2000) and TED Aliaga Private High School, Izmir (1999).
Her publications include: 'Hurdles To Effective Pharmaceutical Patent Protection In Turkey', Mondaq, February 12 2013; 'Patentability of new medical uses of known active pharmaceutical ingredients under Turkish Patent Law', IBA IP and Entertainment Law Committee Newsletter, September 2012; 'The Use and Enforcement of IP Rights in the Pharma Sector from the Perspective of Competition Law', The Annual Symposium on Recent Developments in Competition Law VIII – Erciyes University & Turkish Competition Authority, 2010; and 'Avoiding the Confusion of Medications', Managing Intellectual Property, December 2008-January 2009.
Özge is a member of the Turkish and Istanbul Bar Unions, International Bar Association (vice-chair Patent Sub-committee), Drug Information Association, Trans European Law Firms Alliance (Marketing Committee member), Galatasaray University Alumni Association, and European Law Students Association.